?????????????.??????????????????????????????????????Duvelisib was the 2nd PI3K inhibitor approved from the FDA, also depending on a stage III randomized trial.130 The efficacy and security profile in the drug look comparable with those of idelalisib, if not slightly advantageous. Regarding alternative BTK inhibitors, there are lots of merchandise i